In 2023, Germany led global government expenditure on R&D in medical and health sciences, with an expenditure of 24.96 million US Dollars PPP, followed by Japan and Spain. Key growth leaders included Germany with an 11.27% year-on-year increase and Iceland with a staggering 13.47% rise. Conversely, the United Kingdom and the Netherlands saw declines of 14.2% and 5.7% respectively. Over the last five years, countries like Slovakia have demonstrated significant growth in R&D investments.
Future trends to watch include increased R&D funding driven by technological advancements in medical sciences and heightened global health challenges. Emerging markets may also boost investments to enhance domestic healthcare solutions.
Top countries in Government Expenditure on R&D in Medical and Health Sciences Share by Country (Million US Dollars PPP)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 24.96 | 2023 | +11.88% | +11.27% | View data |
| 2 | 2 Japan | 15.54 | 2023 | +6.58% | +7.7% | View data |
| 3 | 3 Spain | 13.03 | 2023 | +3.87% | +5.15% | View data |
| 4 | 4 Russia | 10.7 | 2023 | +3.01% | +2.58% | View data |
| 5 | 5 Italy | 10.22 | 2023 | +4.14% | +5.78% | View data |
| 6 | 6 Taiwan | 8.38 | 2023 | +2.19% | +2.54% | View data |
| 7 | 7 Singapore | 4.08 | 2023 | +6.14% | +8% | View data |
| 8 | 8 South Korea | 3.36 | 2023 | +8.77% | +3.65% | View data |
| 9 | 9 Norway | 1.7 | 2023 | +3.51% | +4.1% | View data |
| 10 | 10 Portugal | 0.86 | 2023 | +2.02% | +5.02% | View data |
